CTLA4 and triple-A syndrome: On the other hand, we found a significant decrease in the incidence (66%, P = 0.0104) and mortality (26%, P = 0.031) of AAA in angiotensin II-infused CTLA-4-Tg/Apoe−/− mice (Fig. 1B–E).